Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gongxuening Capsule to Reduce Post-Abortion Bleeding
ChiCTR2200059479Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative hemorrhage comparing Gongxuening Capsule with Placebo capsule (2 arms). Primary endpoint: Vaginal bleeding volume. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
gongxuening
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on ChiCTR2200059479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059479.